PG
Insider
Peter Greenleaf
Chief Executive OfficerPeter Greenleaf (Chief Executive Officer) filed 1 Form 4 report in the past 24 months (0 purchases, 1 sale), most often in Aurinia Pharmaceuticals Inc. (AUPH). The largest single filing was $2.9M of AUPH (360,540 sh across 2 lots, as filed), executed Mar 3 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$2.9M
shares × price, as filed
Last traded
Mar 4 2025
Filed Mar 4 2025
Median ADV $22.3M across their filed names
Open performance→Volume by month
Buys $0
Sells $2.9M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 24 months
Most traded names
AUPHRecent filings
AUPHSALE
Aurinia Pharmaceuticals Inc.
View filing →
$2.9M360,540 sh across 2 lots
Exec Mar 3 2025
Filed Mar 4 2025 · 5:30 PM ET